• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾衰竭时肠道细胞色素P450的下调

Downregulation of intestinal cytochrome p450 in chronic renal failure.

作者信息

Leblond Francois A, Petrucci Martin, Dubé Pierre, Bernier Gilbert, Bonnardeaux Alain, Pichette Vincent

机构信息

Nephrology Service and Centre de Recherche Guy-Bernier, Hôpital Maisonneuve-Rosemont, Faculty of Medicine, Université de Montréal, Québec, Canada.

出版信息

J Am Soc Nephrol. 2002 Jun;13(6):1579-85. doi: 10.1097/01.asn.0000017575.50319.77.

DOI:10.1097/01.asn.0000017575.50319.77
PMID:12039987
Abstract

Chronic renal failure (CRF) is associated with a decrease in intestinal drug metabolism. The mechanisms remain poorly understood, but one hypothesis involves a reduction in cytochrome P450 levels. This study aimed to investigate the effects of CRF on intestinal cytochrome P450. Two groups of rats were defined, i.e., rats with CRF (induced by 5/6 nephrectomy) and control pair-fed rats. Total cytochrome P450 levels and protein and mRNA expression of cytochrome P450 isoforms, as well as in vitro N-demethylation of erythromycin (a probe for CYP3A activity) and 7-ethoxyresorufin o-deethylase activity (a probe for CYP1A), were assessed in intestinal microsomes. Body weights were similar in the two groups. Creatinine clearance was reduced by 77% (P < 0.001) in CRF rats, compared with control pair-fed animals. Total intestinal cytochrome P450 activity was reduced by 32% (P < 0.001) in CRF rats. CYP1A1 and CYP3A2 protein expression was considerably reduced (>40%, P < 0.001) in rats with CRF. CYP2B1, CYP2C6, and CYP2C11 levels were the same in the two groups. RT-PCR assays revealed marked downregulation of CYP1A1 and CYP3A2 gene expression in CRF rats (P < 0.001). Although intestinal cytochrome P450 levels were reduced in CRF, induction by dexamethasone was present. N-Demethylation of erythromycin and 7-ethoxyresorufin o-deethylase activity were decreased by 25% (P < 0.05) in CRF rats, compared with control rats. In conclusion, CRF in rats is associated with decreases in intestinal cytochrome P450 activity (mainly CYP1A1 and CYP3A2) secondary to reduced gene expression.

摘要

慢性肾衰竭(CRF)与肠道药物代谢降低有关。其机制仍知之甚少,但有一种假说认为与细胞色素P450水平降低有关。本研究旨在探讨CRF对肠道细胞色素P450的影响。定义了两组大鼠,即CRF大鼠(通过5/6肾切除术诱导)和对照配对喂养大鼠。评估了肠道微粒体中细胞色素P450的总水平、细胞色素P450同工酶的蛋白质和mRNA表达,以及红霉素的体外N-去甲基化(CYP3A活性探针)和7-乙氧基异吩恶唑酮O-脱乙基酶活性(CYP1A探针)。两组大鼠体重相似。与对照配对喂养动物相比,CRF大鼠的肌酐清除率降低了77%(P<0.001)。CRF大鼠的肠道细胞色素P450总活性降低了32%(P<0.001)。CRF大鼠中CYP1A1和CYP3A2蛋白表达显著降低(>40%,P<0.001)。两组中CYP2B1、CYP2C6和CYP2C11水平相同。RT-PCR分析显示CRF大鼠中CYP1A1和CYP3A2基因表达明显下调(P<0.001)。虽然CRF中肠道细胞色素P450水平降低,但地塞米松仍可诱导其表达。与对照大鼠相比,CRF大鼠中红霉素的N-去甲基化和7-乙氧基异吩恶唑酮O-脱乙基酶活性降低了25%(P<0.05)。总之,大鼠中的CRF与基因表达降低继发的肠道细胞色素P450活性(主要是CYP1A1和CYP3A2)降低有关。

相似文献

1
Downregulation of intestinal cytochrome p450 in chronic renal failure.慢性肾衰竭时肠道细胞色素P450的下调
J Am Soc Nephrol. 2002 Jun;13(6):1579-85. doi: 10.1097/01.asn.0000017575.50319.77.
2
Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.慢性肾衰竭对大鼠脑细胞色素P450的影响。
Drug Metab Dispos. 2016 Aug;44(8):1174-9. doi: 10.1124/dmd.116.070052. Epub 2016 Jun 6.
3
Downregulation of hepatic cytochrome P450 in chronic renal failure.慢性肾衰竭时肝细胞色素P450的下调
J Am Soc Nephrol. 2001 Feb;12(2):326-332. doi: 10.1681/ASN.V122326.
4
Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.慢性肾衰竭时肝脏细胞色素P450的下调:尿毒症介质的作用
Br J Pharmacol. 2002 Dec;137(7):1039-46. doi: 10.1038/sj.bjp.0704951.
5
Strain differences in hepatic cytochrome P450 1A and 3A expression between Sprague-Dawley and Wistar rats.斯普拉格-道利大鼠和Wistar大鼠肝脏细胞色素P450 1A和3A表达的品系差异。
J Toxicol Sci. 2008 Oct;33(4):447-57. doi: 10.2131/jts.33.447.
6
Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.慢性肾衰竭小鼠模型中肝药物代谢酶的下调。
Drug Metab Dispos. 2010 Mar;38(3):357-60. doi: 10.1124/dmd.109.029991. Epub 2009 Dec 9.
7
Decreased in vivo metabolism of drugs in chronic renal failure.慢性肾衰竭时药物的体内代谢降低。
Drug Metab Dispos. 2000 Nov;28(11):1317-20.
8
Down-regulation of hepatic CYP3A in chronic renal insufficiency.慢性肾功能不全时肝脏CYP3A的下调
Pharm Res. 2003 Oct;20(10):1600-6. doi: 10.1023/a:1026135317578.
9
Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450.慢性肾衰竭患者血清对大鼠肝脏细胞色素P450的影响。
Br J Pharmacol. 2005 Apr;144(8):1067-77. doi: 10.1038/sj.bjp.0706138.
10
Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.胆管结扎对雄性和雌性大鼠肝脏中雌性特异性CYP2C12表达的影响。
Hepatology. 1998 Sep;28(3):624-30. doi: 10.1002/hep.510280304.

引用本文的文献

1
Simultaneous determination of the combined and free concentrations of atorvastatin and its major metabolite and based on ultrafiltration coupled with UPLC-MS/MS method: an application in a protein binding rate and metabolism ability study in uremic hemodialysis patients.基于超滤结合超高效液相色谱-串联质谱法同时测定阿托伐他汀及其主要代谢物的结合型和游离型浓度:在尿毒症血液透析患者蛋白结合率及代谢能力研究中的应用
Front Cardiovasc Med. 2024 Oct 24;11:1461181. doi: 10.3389/fcvm.2024.1461181. eCollection 2024.
2
Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients.慢性肾脏病患者血栓形成和出血风险的特征。
Int J Mol Sci. 2024 Aug 9;25(16):8705. doi: 10.3390/ijms25168705.
3
The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage.
肿瘤肾脏病领域:个性化化疗在预防肾损伤中的作用
Cancers (Basel). 2023 Apr 12;15(8):2254. doi: 10.3390/cancers15082254.
4
Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients.肾功能对冠心病患者替格瑞洛诱导的抗血小板作用的影响。
Int J Cardiol Heart Vasc. 2023 Mar 27;46:101195. doi: 10.1016/j.ijcha.2023.101195. eCollection 2023 Jun.
5
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4-Mediated Metabolism of Saxagliptin.应用生理药代动力学模型评估慢性肾脏病对沙格列汀经 CYP3A4 代谢的影响。
J Clin Pharmacol. 2022 Aug;62(8):1018-1029. doi: 10.1002/jcph.2043. Epub 2022 Apr 4.
6
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites.肾功能损害对阿布昔替尼及其代谢物的药代动力学的影响。
J Clin Pharmacol. 2022 Apr;62(4):505-519. doi: 10.1002/jcph.1980. Epub 2022 Feb 15.
7
The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia.慢性髓性白血病患者血液透析和肝硬化对酪氨酸激酶抑制剂血药浓度的影响。
Intern Med. 2020 Nov 1;59(21):2745-2749. doi: 10.2169/internalmedicine.4871-20. Epub 2020 Jul 7.
8
Pharmacokinetics in children with chronic kidney disease.儿童慢性肾脏病的药代动力学。
Pediatr Nephrol. 2020 Jul;35(7):1153-1172. doi: 10.1007/s00467-019-04304-9. Epub 2019 Aug 2.
9
Emerging Roles of Aryl Hydrocarbon Receptors in the Altered Clearance of Drugs during Chronic Kidney Disease.芳香烃受体在慢性肾脏病期间药物清除改变中的新兴作用。
Toxins (Basel). 2019 Apr 7;11(4):209. doi: 10.3390/toxins11040209.
10
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.涉及细胞色素 P450 的复杂药物-药物-基因-疾病相互作用:已发表病例报告的系统评价和临床观点。
Clin Pharmacokinet. 2018 Oct;57(10):1267-1293. doi: 10.1007/s40262-018-0650-9.